143 related articles for article (PubMed ID: 35802846)
1. An updated list of drugs suspected to be associated with immune thrombocytopenia based on the WHO pharmacovigilance database.
Fuentes S; Chrétien B; Dolladille C; Alexandre J; Dumont A; Nguyen A; de Boysson H; Chèze S; Maigné G; Aouba A; Deshayes S
Blood; 2022 Aug; 140(8):922-927. PubMed ID: 35802846
[No Abstract] [Full Text] [Related]
2. Safety Profile of Eltrombopag in Different Age Groups: An Analysis of Real-World Pharmacovigilance and Randomized Clinical Trials.
Qu H; Wu J; Ma C; Qiaolongbatu X; Song X; Feng T; Wu Z; Lou Y; Fan G
Clin Pharmacol Ther; 2023 Jul; 114(1):201-210. PubMed ID: 37087633
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced immune thrombocytopenia: a descriptive survey in the French PharmacoVigilance database.
Moulis G; Sommet A; Sailler L; Lapeyre-Mestre M; Montastruc JL;
Platelets; 2012; 23(6):490-4. PubMed ID: 22098130
[TBL] [Abstract][Full Text] [Related]
4. Changing spectrum of suspected drugs of epidermal necrolysis: A World Health Organization pharmacovigilance database analysis from 1997-2020.
Bettuzzi T; Ingen-Housz-Oro S; Purtillo CC; Le Cleach L; Maison P; de Prost N; Wolkenstein P; Lebrun-Vignes B; Sbidian E
J Am Acad Dermatol; 2021 Dec; 85(6):1581-1584. PubMed ID: 33217509
[No Abstract] [Full Text] [Related]
5. Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis.
Murarasu A; Bertoliatti-Fontana G; Massy N; Bagheri H; Treluyer JM; Regent A; Chouchana L
Therapie; 2023; 78(3):328-330. PubMed ID: 35697538
[No Abstract] [Full Text] [Related]
6. Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine.
Saudagar V; Patil S; Goh S; Pothiawala S
Ir J Med Sci; 2022 Apr; 191(2):919-920. PubMed ID: 33788135
[TBL] [Abstract][Full Text] [Related]
7. Safety of pitolisant: a study in the WHO international pharmacovigilance database.
Montastruc JL
Eur J Clin Pharmacol; 2023 Apr; 79(4):569-570. PubMed ID: 36892631
[No Abstract] [Full Text] [Related]
8. Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database.
Bettuzzi T; Drucker A; Staumont-Sallé D; Bihan K; Lebrun-Vignes B; Sbidian E
J Am Acad Dermatol; 2022 Feb; 86(2):431-433. PubMed ID: 34600034
[No Abstract] [Full Text] [Related]
9. Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database.
Campillo JT; Faillie JL
Therapie; 2022; 77(6):747-749. PubMed ID: 35606189
[No Abstract] [Full Text] [Related]
10. Characterization of drug-induced cutaneous lupus: Analysis of 1994 cases using the WHO pharmacovigilance database.
Kawka L; Mertz P; Chasset F; Lebrun-Vignes B; Salem JE; Arnaud L
Autoimmun Rev; 2021 Jan; 20(1):102705. PubMed ID: 33188917
[No Abstract] [Full Text] [Related]
11. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database.
Montastruc JL; Lafaurie M; de Canecaude C; Durrieu G; Sommet A; Montastruc F; Bagheri H
Br J Clin Pharmacol; 2021 Nov; 87(11):4334-4340. PubMed ID: 33837554
[TBL] [Abstract][Full Text] [Related]
12. Antineoplastic Drug-induced Aortitis: An Unraveled Adverse Effect Using the World Health Organization Pharmacovigilance Database.
Mettler C; Chouchana L; Terrier B
J Rheumatol; 2020 Aug; 47(8):1298-1300. PubMed ID: 32482651
[No Abstract] [Full Text] [Related]
13. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
[TBL] [Abstract][Full Text] [Related]
14. Immune-Mediated Adverse Drug Reactions (IM-ARDs) in the Form of Drug-Induced Immune Thrombocytopenia and Cutaneous Adverse Drug Reactions (CARD) Due to Clindamycin in an Human Immunodeficieny Virus (HIV) Patient.
Hardjo Lugito NP; Kurniawan A; Jayadi NN; Kristiani E
Am J Case Rep; 2023 Jan; 24():e938358. PubMed ID: 36600572
[TBL] [Abstract][Full Text] [Related]
15. Temporal data mining for adverse events following immunization in nationwide Danish healthcare databases.
Svanström H; Callréus T; Hviid A
Drug Saf; 2010 Nov; 33(11):1015-25. PubMed ID: 20925439
[TBL] [Abstract][Full Text] [Related]
16. [Immune Thrombocytopenia Induced by Sintilimab in Lung Cancer:
A Case Report and Literature Review].
Cai J; Yang G; Zhang X; Liu L; Yan M
Zhongguo Fei Ai Za Zhi; 2023 Sep; 26(9):717-720. PubMed ID: 37985158
[TBL] [Abstract][Full Text] [Related]
17. Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO's pharmacovigilance database.
Anquetil C; Salem JE; Lebrun-Vignes B; Touhami S; Desbois AC; Maalouf G; Domont F; Allenbach Y; Cacoub P; Bodaghi B; Saadoun D
J Autoimmun; 2020 Jul; 111():102454. PubMed ID: 32303423
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and current management of venous thromboembolism in patients with primary immune thrombocytopenic purpura.
Tana M; Tana C; Rizzo G; Ricci F; Porreca E
Eur J Intern Med; 2021 Apr; 86():121-123. PubMed ID: 33568328
[No Abstract] [Full Text] [Related]
19. Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.
Al-Husban N; Al-Kuran O
J Med Case Rep; 2018 Jun; 12(1):147. PubMed ID: 29855343
[TBL] [Abstract][Full Text] [Related]
20. Biologic immunomodulatory medications and autoimmune cytopenias: A cross-sectional analysis of a national surveillance database.
Bibb LA; Adkins BD; Stephens LD; Booth GS; Jacobs JW
J Am Acad Dermatol; 2024 Jul; 91(1):153-156. PubMed ID: 38513833
[No Abstract] [Full Text] [Related]
[Next] [New Search]
